Last time I looked at AngioDynamics, Inc. (NASDAQ: ANGO ), I rated the stock a Buy. My reasoning was around the fact that the company has a growing set of medical technologyI focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst’s Disclosure:I/we have a beneficial long position in the shares of A ...